Most Americans support psilocybin use for mental health and well-being, a new study shows, marking a shift in attitudes toward psychedelics.

Intra-Cellular Therapies' lumateperone shows significant efficacy in reducing schizophrenia relapse rates, with a 63% risk ...

The study also included an 18-week open-label phase, during which patients with Schizophrenia were treated with Lumateperone 42 mg per day. The biopharmaceutical company found that the time to relapse ...

While Depression is fast emerging as a leading health issue, a major hurdle in its treatment is lack of detection. The WHO notes that although there are known, effective treatments ... irritability is ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...

Research suggests relapses can lead to harm, reduce the quality of life, and have a heavy economic impact on patients with ...

Art therapy can help individuals express thoughts and feelings without relying solely on words, providing a valuable outlet ...

The distress from voices heard by schizophrenia patients were lessened when treated using digital avatars, new study showed.

A new multi-site trial from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found ...

Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October). More evidence is needed on the clinical ...

The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for the disease safe for use but the rationing body has immediately ruled ...

Recognising the valuable role of psychotherapy in managing schizophrenia alongside medication is essential for the most effective treatment. This guide explores psychotherapeutic approaches tailored ...